Identifying Tubulocystic Renal Cell Carcinoma

Tubulocystic renal cell carcinoma (TCRCC) represents a rare but distinct subtype of renal cancer that often poses diagnostic challenges for clinicians. Because this malignancy frequently mimics benign cystic lesions, specialists may find it difficult to reach a definitive diagnosis using standard computed tomography (CT) alone. However, recent evidence emphasizes that ultrasound plays a critical role in distinguishing this rare neoplasm from simple cysts. Specifically, the unique echogenic properties of this tumor allow for better characterization when other modalities yield equivocal results.

Diagnostic Features on Ultrasound

In many clinical scenarios, tubulocystic renal cell carcinoma appears as a hyperechoic mass when viewed under ultrasound. This specific high echogenicity helps differentiate it from typical benign cysts, which usually appear anechoic. Furthermore, most TCRCC lesions demonstrate posterior acoustic enhancement. This feature remains highly useful when CT or magnetic resonance imaging (MRI) findings are non-specific. Researchers recently reviewed seven pathologically confirmed cases to better understand these imaging nuances.

Notably, four of the reviewed cases were detected incidentally during routine examinations. Patients who did show symptoms commonly reported abdominal pain or hematuria. On CT scans, these masses typically demonstrated low attenuation, with a mean of 15 Hounsfield Units (HU). Consequently, such findings can easily be mistaken for benign fluid-filled cysts. Therefore, clinicians should consider ultrasound as a mandatory supplementary tool whenever a renal mass appears indeterminate on a CT scan.

The Advantage of Multimodality Imaging

While MRI can visualize septal enhancement or mural nodules, it often characterizes TCRCC as T1 hypointense and T2 hyperintense. This appearance might lead a radiologist to classify the lesion incorrectly using the Bosniak system. However, the study found that hyperechoic portions on ultrasound often corresponded directly to enhancing areas seen on MRI. Moreover, Contrast-Enhanced Ultrasound (CEUS) can reveal vital septal enhancement that traditional CT might overlook. In addition to improving diagnostic accuracy, ultrasound provides a cost-effective and radiation-free method for initial assessment.

Frequently Asked Questions

How does tubulocystic renal cell carcinoma appear on an ultrasound?

It most commonly appears as a uniformly hyperechoic or mixed echogenic mass. A key diagnostic feature is posterior acoustic enhancement, which is almost always present in these tumors.

Why is CT scanning sometimes insufficient for TCRCC?

On CT, this carcinoma often shows low attenuation and variable enhancement. These characteristics mimic benign simple or complex cysts, potentially leading to a delayed diagnosis.

What are the common symptoms of this condition?

Many patients remain asymptomatic, and clinicians find the tumor incidentally. However, some individuals may experience hematuria or localized abdominal pain.

Disclaimer: This content is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Choi R et al. Important Role of Ultrasound in Assessing Tubulocystic Renal Cell Carcinoma. Ultrasound Q. 2026 Jun 01. doi: undefined. PMID: 42044518.


2. Cornelis F, et al. Tubulocystic renal cell carcinoma: a new radiological entity. Eur Radiol. 2016;26(8):2620-2629.


3. Radiopaedia.org. Tubulocystic renal cell carcinoma. Accessed April 2026.